Esperion Therapeutics, Inc. 4
4 · Esperion Therapeutics, Inc. · Filed Feb 22, 2017
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2017-02-21+10,800→ 10,800 totalExercise: $24.42Exp: 2027-02-21→ Common Stock (10,800 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on May 21, 2017.